Selbyville, Delaware, June 12, 2023 (GLOBE NEWSWIRE) —
3.1    Industry ecosystem analysis
3.2    Industry impact forces
3.2.1    Growth drivers
3.2.1.1   Increasing number of drug targets for screening
3.2.1.2   Technological Advancements in HTS
3.2.1.3   Rise in overall funding and capital investments
3.2.1.4   Surging adoption of open innovation models in pharma and biotech companies
3.2.2    Industry pitfalls & challenges
3.2.2.1   Complexities in assay development process
3.2.2.2   High cost of HTS instruments
3.3    Growth potential analysis
3.3.1    By products and services
3.3.2    By technology
3.3.3    By application
3.3.4    By end-use
3.4    COVID-19 impact analysis
Chapter 4   Competitive Landscape, 20224.1    Introduction
4.2    Company matrix analysis, 2022
4.3    Competitive positioning matrix
4.4    Vendor matrix analysis
4.5    Strategy dashboard, 2022
(GlobeNewsWire)